February 13, 2025
1 min read
A recent cohort study published in JAMA Network Open investigated the behaviors of approximately 386,000 women, revealing that nearly 50% of those who were on antidepressant medications before conceiving chose to discontinue their treatment during pregnancy, opting not to substitute it with psychotherapy.
Interestingly, within just one month postpartum, these women returned to their average level of antidepressant prescriptions, indicating a striking trend in maternal mental health care.
Claire Boone, PhD, an assistant professor in the departments of economics and equity, ethics and policy at McGill University, emphasized, “This suggests a gap in mental health care during pregnancy that could leave many women effectively untreated during a critical period.”
Additional Insights in Women’s Health
Last week, this topic was a leading story in women’s health discussions. Another significant theme emerged regarding the outcomes for postmenopausal women suffering from vulvovaginal atrophy: those treated with intravaginal prasterone for a minimum of three months exhibited nearly a 50% reduction in urinary tract infections (UTIs) compared to untreated counterparts.
Top Stories in Women’s Health
Discontinuation of Antidepressants During Pregnancy
Nearly half of women on antidepressants prior to conception stopped their use during pregnancy without shifting to psychotherapy, according to the study results. Read more.
Intravaginal Prasterone and UTI Risk
Treatment with intravaginal prasterone significantly lowers the risk of developing UTIs in postmenopausal women suffering from vulvovaginal atrophy, as reported in the research published in Menopause. Read more.
Maternal Mortality: Violence vs. Medical Causes
The data reveals that pregnant women face a higher risk of death due to violence rather than any medical condition, highlighting the urgent need for screening for intimate partner violence. Read more.
Medication Abortion Viability
According to proof-of-concept studies, a combination of Ulipristal acetate followed by misoprostol proved to be an effective and safe option for medication abortion up to 63 days’ gestation, though further studies are necessary. Read more.
Low-Dose Aspirin Initiative for Black Women
The Preeclampsia Foundation has initiated a program aimed at closing the maternal health equity gap, advocating for the use of low-dose aspirin to lower preeclampsia risks in Black women. Read more.
